Matthew Kurian: The Era of oral novel SERDs in Breast Cancer is here

Elvina Almuradova: The FDA has granted fast track designation to 67Cu-SAR-bisPSMA for PSMA-positive mCRPC

Tanja Obradovic: New option of immunotherapy for HNSCC is on the horizon

Ocular Side Effects of Chemotherapy: Understanding the Risks of Eye Toxicity

FDA approves Vimseltinib(Romvimza) for symptomatic Tenosynovial Giant Cell Tumor (TGCT)

The FDA has approved vimseltinib by Deciphera Pharmaceuticals for TGCT – The Babak Lab

Patrizia Cavazzoni Rejoins Pfizer as Chief Medical Officer and Executive Vice President

FDA Authorizes ImmunityBio to Provide Recombinant BCG as Alternative to TICE BCG Shortage for Bladder Cancer

Senator Edward Markey in Response to OncoDaily About Pediatric Cancer Funding

Danielle Bitterman Calls on Conference Leaders to Provide Hybrid Options for HHS-Funded Scientists